The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
10x Genomics Inc | CL A COM | 88025U109 | 128,784 | 711,515 | SH | SOLE | 1,2,3 | 711,515 | 0 | 0 | |
5 01 Acquisition Corp | COM CL A | 33836P105 | 3,900 | 392,000 | SH | SOLE | 1,2,3 | 392,000 | 0 | 0 | |
908 Devices Inc | COM | 65443P102 | 1,940 | 40,000 | SH | SOLE | 1,2,3 | 40,000 | 0 | 0 | |
Acutus Med Inc | COM | 005111109 | 6,041 | 451,834 | SH | SOLE | 1,2,3 | 451,834 | 0 | 0 | |
Adverum Biotechnologies Inc | COM | 00773U108 | 72,461 | 7,348,976 | SH | SOLE | 1,2,3 | 7,348,976 | 0 | 0 | |
Agenus Inc | COM NEW | 00847G705 | 37,474 | 13,777,244 | SH | SOLE | 1,2,3 | 13,777,244 | 0 | 0 | |
Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 237,674 | 1,683,362 | SH | SOLE | 1,2,3 | 1,683,362 | 0 | 0 | |
Aptevo Therapeutics Inc | COM NEW | 03835L207 | 8,588 | 281,402 | SH | SOLE | 1,2,3 | 281,402 | 0 | 0 | |
Apyx Medical Corporation | COM | 03837C106 | 32,760 | 3,391,279 | SH | SOLE | 1,2,3 | 3,391,279 | 0 | 0 | |
Arbutus Biopharma Corp | COM | 03879J100 | 19,908 | 5,978,355 | SH | SOLE | 1,2,3 | 5,978,355 | 0 | 0 | |
argenx SE | SPONSORED ADR | 04016X101 | 8,744 | 31,752 | SH | SOLE | 1,2 | 31,752 | 0 | 0 | |
Arvinas Inc | COM | 04335A105 | 107,267 | 1,622,799 | SH | SOLE | 1,2,3 | 1,622,799 | 0 | 0 | |
Arya Sciences Acquisition Co | COM CL A | G3166W106 | 6,890 | 500,000 | SH | SOLE | 1,2,3 | 500,000 | 0 | 0 | |
Arya Sciences Acqu Corp IV | CL A | G31659108 | 5,236 | 500,000 | SH | SOLE | 1,2,3 | 500,000 | 0 | 0 | |
Aslan Pharmaceuticals Ltd | ADS | 04522R101 | 10,888 | 3,250,000 | SH | SOLE | 1,2,3 | 3,250,000 | 0 | 0 | |
Athira Pharma Inc | COM | 04746L104 | 48,807 | 2,652,553 | SH | SOLE | 1,2,3 | 2,652,553 | 0 | 0 | |
Avadel Pharmaceuticals plc | SPONSORED ADR | 05337M104 | 51,907 | 5,741,939 | SH | SOLE | 1,2,3 | 5,741,939 | 0 | 0 | |
Avidity Biosciences Inc | COM | 05370A108 | 87,131 | 3,995,000 | SH | SOLE | 1,2,3 | 3,995,000 | 0 | 0 | |
Avita Medical Inc | COM | 05380C102 | 5,550 | 280,000 | SH | SOLE | 1,2,3 | 280,000 | 0 | 0 | |
Axonics Modulation Technolog | COM | 05465P101 | 112,825 | 1,883,864 | SH | SOLE | 1,2,3 | 1,883,864 | 0 | 0 | |
Axsome Therapeutics Inc | COM | 05464T104 | 91,526 | 1,616,497 | SH | SOLE | 1,2,3 | 1,616,497 | 0 | 0 | |
Aziyo Biologics Inc | COM CL A | 05479K106 | 1,728 | 125,000 | SH | SOLE | 1,2,3 | 125,000 | 0 | 0 | |
Bcls Acquisition Corp | COM CL A | G0904B105 | 6,474 | 612,500 | SH | SOLE | 1,2,3 | 612,500 | 0 | 0 | |
BCTG Acquisition Corp | COM | 05492W103 | 6,672 | 600,000 | SH | SOLE | 1,2,3 | 600,000 | 0 | 0 | |
Bellus Health Inc New | COM NEW | 07987C204 | 19,040 | 4,968,017 | SH | SOLE | 1,2,3 | 4,968,017 | 0 | 0 | |
Berkeley Lts Inc | COM | 084310101 | 12,937 | 257,546 | SH | SOLE | 1,2,3 | 257,546 | 0 | 0 | |
Bioatla Inc | COM | 09077B104 | 508 | 10,000 | SH | SOLE | 1,2,3 | 10,000 | 0 | 0 | |
Biodesix Inc | COM | 09075X108 | 2,539 | 125,000 | SH | SOLE | 1,2,3 | 125,000 | 0 | 0 | |
Bolt Biotherapeutics Inc | COM | 097702104 | 4,937 | 150,000 | SH | SOLE | 1,2,3 | 150,000 | 0 | 0 | |
Brainsway Ltd | SPONSORED ADS | 10501L106 | 14,468 | 1,602,181 | SH | SOLE | 1,2,3 | 1,602,181 | 0 | 0 | |
Burning Rock Biotech Ltd | SPONSORED ADS | 12233L107 | 808 | 30,000 | SH | SOLE | 1,2,3 | 30,000 | 0 | 0 | |
C4 Therapeutics Inc | COM STK | 12529R107 | 79,437 | 2,149,228 | SH | SOLE | 1,2,3 | 2,149,228 | 0 | 0 | |
Castle Biosciences Inc | COM | 14843C105 | 54,700 | 799,009 | SH | SOLE | 1,2,3 | 799,009 | 0 | 0 | |
Celldex Therapeutics Inc New | COM NEW | 15117B202 | 80,524 | 3,908,947 | SH | SOLE | 1,2,3 | 3,908,947 | 0 | 0 | |
Cerevel Therapeutics Hldng I | COM | 15678U128 | 6,865 | 500,000 | SH | SOLE | 1,2,3 | 500,000 | 0 | 0 | |
Cerevel Therapeutics Hldng I | *W EXP 06/09/202 | 15678U102 | 718 | 166,666 | SH | SOLE | 1,2,3 | 166,666 | 0 | 0 | |
Cerner Corp | COM | 156782104 | 127,550 | 1,774,485 | SH | SOLE | 1,2,3 | 1,774,485 | 0 | 0 | |
Chardan Healthcr Acqstn 2 Co | UNIT 99/99/9999 | 15957T206 | 3,682 | 350,000 | SH | SOLE | 1,2,3 | 350,000 | 0 | 0 | |
Chardan Healthcr Acqstn 2 Co | COM | 15957T107 | 8,417 | 837,540 | SH | SOLE | 1,2,3 | 837,540 | 0 | 0 | |
Clearside Biomedical Inc | COM | 185063104 | 10,391 | 4,206,765 | SH | SOLE | 1,2,3 | 4,206,765 | 0 | 0 | |
Connect Biopharma Holdings Ltd | ADS | 207523101 | 8,325 | 450,000 | SH | SOLE | 1,2,3 | 450,000 | 0 | 0 | |
Curis Inc | COM NEW | 231269200 | 40,973 | 3,619,544 | SH | SOLE | 1,2,3 | 3,619,544 | 0 | 0 | |
Cytokinetics Inc | COM NEW | 23282W605 | 46,520 | 2,000,000 | SH | SOLE | 1,2,3 | 2,000,000 | 0 | 0 | |
Cytomx Therapeutics Inc | COM | 23284F105 | 11,856 | 1,533,758 | SH | SOLE | 1,2,3 | 1,533,758 | 0 | 0 | |
DermTech Inc | COM | 24984K105 | 158,397 | 3,118,665 | SH | SOLE | 1,2,3 | 3,118,665 | 0 | 0 | |
Dicerna Pharmaceuticals Inc | COM | 253031108 | 190,836 | 7,463,291 | SH | SOLE | 1,2,3 | 7,463,291 | 0 | 0 | |
Essa Pharma Inc | COM NEW | 29668H708 | 8,241 | 283,692 | SH | SOLE | 1,2,3 | 283,692 | 0 | 0 | |
Establishment Labs Hldgs Inc | COM | G31249108 | 145,016 | 2,319,138 | SH | SOLE | 1,2,3 | 2,319,138 | 0 | 0 | |
Exagen Inc | COM | 30068X103 | 28,461 | 1,626,365 | SH | SOLE | 1,2,3 | 1,626,365 | 0 | 0 | |
Fulcrum Therapeutics Inc | COM | 359616109 | 37,758 | 3,205,291 | SH | SOLE | 1,2,3 | 3,205,291 | 0 | 0 | |
Genetron Hldgs Ltd | ADS | 37186H100 | 39,018 | 1,818,162 | SH | SOLE | 1,2,3 | 1,818,162 | 0 | 0 | |
Globus Med Inc | CL A | 379577208 | 103,039 | 1,670,811 | SH | SOLE | 1,2,3 | 1,670,811 | 0 | 0 | |
Guardant Health Inc | COM | 40131M109 | 93,082 | 609,774 | SH | SOLE | 1,2,3 | 609,774 | 0 | 0 | |
Helix Acquisition Corp | COM CL A | G4444C102 | 7,658 | 750,000 | SH | SOLE | 1,2,3 | 750,000 | 0 | 0 | |
Ideaya Biosciences Inc | COM | 45166A102 | 57,957 | 2,466,255 | SH | SOLE | 1,2,3 | 2,466,255 | 0 | 0 | |
Illumina Inc | COM | 452327109 | 185,100 | 481,956 | SH | SOLE | 1,2,3 | 481,956 | 0 | 0 | |
Immatics N.V | SHS | N44445109 | 3,924 | 350,000 | SH | SOLE | 1,2,3 | 350,000 | 0 | 0 | |
Immunic Inc | COM | 4525EP101 | 14,678 | 920,814 | SH | SOLE | 1,2,3 | 920,814 | 0 | 0 | |
Immunocore Hldgs PLC | ADS | 45258D105 | 50,142 | 1,245,532 | SH | SOLE | 1,2,3 | 1,245,532 | 0 | 0 | |
Immunovant Inc | COM | 45258J102 | 101,962 | 6,356,743 | SH | SOLE | 1,2,3 | 6,356,743 | 0 | 0 | |
Inmode Ltd | SHS | M5425M103 | 9,046 | 124,999 | SH | SOLE | 1,2 | 124,999 | 0 | 0 | |
Itamar Med Ltd | SPONSORED ADS | 465437101 | 6,433 | 268,609 | SH | SOLE | 1,2,3 | 268,609 | 0 | 0 | |
Iteos Therapeutics Inc | COM | 46565G104 | 94,432 | 2,762,791 | SH | SOLE | 1,2,3 | 2,762,791 | 0 | 0 | |
IVERIC bio Inc | COM | 46583P102 | 41,546 | 6,722,624 | SH | SOLE | 1,2,3 | 6,722,624 | 0 | 0 | |
Johnson & Johnson | COM | 478160104 | 28,029 | 170,542 | SH | SOLE | 1,2,3 | 170,542 | 0 | 0 | |
Kura Oncology Inc | COM | 50127T109 | 30,586 | 1,081,912 | SH | SOLE | 1,2,3 | 1,081,912 | 0 | 0 | |
La Jolla Pharmaceutical Co | COM PAR $.0001 2 | 503459604 | 9,870 | 2,327,903 | SH | SOLE | 1,2,3 | 2,327,903 | 0 | 0 | |
Landos Biopharma Inc | COM | 515069102 | 38,328 | 4,275,722 | SH | SOLE | 1,2,3 | 4,275,722 | 0 | 0 | |
Lifesci Acquisition Ii Corp | COM | 53229E103 | 6,591 | 650,000 | SH | SOLE | 1,2,3 | 650,000 | 0 | 0 | |
MacroGenics Inc | COM | 556099109 | 64,159 | 2,014,400 | SH | SOLE | 1,2,3 | 2,014,400 | 0 | 0 | |
Maravai Lifesciences Hldgs I | COM CL A | 56600D107 | 2,495 | 70,000 | SH | SOLE | 1,2,3 | 70,000 | 0 | 0 | |
Masimo Corp | COM | 574795100 | 136,638 | 594,956 | SH | SOLE | 1,2,3 | 594,956 | 0 | 0 | |
Medicus Sciences Acquisition | UNIT 99/99/9999 | G5960S116 | 2,955 | 300,000 | SH | SOLE | 1,2,3 | 300,000 | 0 | 0 | |
Milestone Pharmaceuticals In | COM | 59935V107 | 24,984 | 4,315,102 | SH | SOLE | 1,2,3 | 4,315,102 | 0 | 0 | |
MiMedx Group Inc | COM | 602496101 | 27,813 | 2,700,320 | SH | SOLE | 1,2,3 | 2,700,320 | 0 | 0 | |
Mirati Therapeutics Inc | COM | 60468T105 | 228,383 | 1,333,232 | SH | SOLE | 1,2,3 | 1,333,232 | 0 | 0 | |
NanoString Technologies Inc | COM | 63009R109 | 52,833 | 804,029 | SH | SOLE | 1,2,3 | 804,029 | 0 | 0 | |
Natera Inc | COM | 632307104 | 173,860 | 1,712,234 | SH | SOLE | 1,2,3 | 1,712,234 | 0 | 0 | |
Nuvation Bio Inc | COM CL A | 67080N101 | 3,135 | 300,000 | SH | SOLE | 1,2,3 | 300,000 | 0 | 0 | |
Nuvation Bio Inc | *W EXP 07/07/202 | 67080N119 | 267 | 100,000 | SH | SOLE | 1,2,3 | 100,000 | 0 | 0 | |
Olink Hldg AB | SPONSORED ADS | 680710100 | 6,690 | 185,838 | SH | SOLE | 1,2,3 | 185,838 | 0 | 0 | |
Outset Med Inc | COM | 690145107 | 37,374 | 687,152 | SH | SOLE | 1,2,3 | 687,152 | 0 | 0 | |
Oyster Pt Pharma Inc | COM | 69242L106 | 34,023 | 1,861,209 | SH | SOLE | 1,2,3 | 1,861,209 | 0 | 0 | |
Personalis Inc | COM | 71535D106 | 3,138 | 127,501 | SH | SOLE | 1,2 | 127,501 | 0 | 0 | |
Pmv Pharmaceuticals Inc | COM | 69353Y103 | 15,923 | 484,133 | SH | SOLE | 1,2,3 | 484,133 | 0 | 0 | |
Profound Med Corp | COM NEW | 74319B502 | 2,459 | 122,098 | SH | SOLE | 1,2,3 | 122,098 | 0 | 0 | |
Progenity Inc | COM | 74319F107 | 476 | 100,000 | SH | SOLE | 1,2,3 | 100,000 | 0 | 0 | |
Prometheus Biosciences Inc | COM | 74349U108 | 51,727 | 3,264,031 | SH | SOLE | 1,2,3 | 3,264,031 | 0 | 0 | |
ProQR Thrapeutics N V | SHS EURO | N71542109 | 42,463 | 6,424,078 | SH | SOLE | 1,2,3 | 6,424,078 | 0 | 0 | |
Protagonist Therapeutics Inc | COM | 74366E102 | 90,841 | 3,507,390 | SH | SOLE | 1,2,3 | 3,507,390 | 0 | 0 | |
PTC Therapeutics Inc | COM | 69366J200 | 250,669 | 5,293,966 | SH | SOLE | 1,2,3 | 5,293,966 | 0 | 0 | |
Pulmonx Corp | COM | 745848101 | 51,668 | 1,129,600 | SH | SOLE | 1,2,3 | 1,129,600 | 0 | 0 | |
Quidel Corp | COM | 74838J101 | 112,391 | 878,533 | SH | SOLE | 1,2,3 | 878,533 | 0 | 0 | |
Regenxbio Inc | COM | 75901B107 | 14,209 | 416,577 | SH | SOLE | 1,2,3 | 416,577 | 0 | 0 | |
Relmada Therapeutics Inc | COM | 75955J402 | 53,897 | 1,530,717 | SH | SOLE | 1,2,3 | 1,530,717 | 0 | 0 | |
Research Alliance Corp II | COM CL A | 760873109 | 6,529 | 637,000 | SH | SOLE | 1,2,3 | 637,000 | 0 | 0 | |
Rocket Pharmaceuticals Inc | COM | 77313F106 | 697,287 | 15,715,286 | SH | SOLE | 1,2,3 | 15,715,286 | 0 | 0 | |
Scholar Rock Holding Corp | COM | 80706P103 | 8,187 | 161,612 | SH | SOLE | 1,2,3 | 161,612 | 0 | 0 | |
Seer Inc | COM CL A | 81578P106 | 200 | 4,000 | SH | SOLE | 1,2,3 | 4,000 | 0 | 0 | |
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 375,029 | 946,255 | SH | SOLE | 1,2,3 | 946,255 | 0 | 0 | |
Stoke Therapeutics Inc | COM | 86150R107 | 141,543 | 3,644,248 | SH | SOLE | 1,2,3 | 3,644,248 | 0 | 0 | |
Tandem Diabetes Care Inc | COM NEW | 875372203 | 100,537 | 1,139,230 | SH | SOLE | 1,2,3 | 1,139,230 | 0 | 0 | |
Tarsus Pharmaceuticals Inc. | COM | 87650L103 | 79,091 | 2,463,601 | SH | SOLE | 1,2,3 | 2,463,601 | 0 | 0 | |
Tela Bio Inc | COM | 872381108 | 20,597 | 1,382,343 | SH | SOLE | 1,2,3 | 1,382,343 | 0 | 0 | |
Therapeutics Acquisition Corp | COM CL A | 88339T103 | 5,150 | 490,000 | SH | SOLE | 1,2,3 | 490,000 | 0 | 0 | |
Translate Bio Inc | COM | 89374L104 | 72,262 | 4,382,199 | SH | SOLE | 1,2,3 | 4,382,199 | 0 | 0 | |
Trillium Therapeutics Inc | COM NEW | 89620X506 | 22,462 | 2,091,389 | SH | SOLE | 1,2,3 | 2,091,389 | 0 | 0 | |
Twist Bioscience Corp | COM | 90184D100 | 2,288 | 18,473 | SH | SOLE | 1,2,3 | 18,473 | 0 | 0 | |
Vericel Corp | COM | 92346J108 | 250,951 | 4,517,570 | SH | SOLE | 1,2,3 | 4,517,570 | 0 | 0 | |
Vincerx Pharma Inc | COM NEW | 92731L106 | 9,650 | 500,000 | SH | SOLE | 1,2,3 | 500,000 | 0 | 0 | |
Vincerx Pharma Inc wts $11.5 Exp. 12/24/2025 | *W EXP 12/24/202 | 92731L114 | 2,020 | 500,000 | SH | SOLE | 1,2,3 | 500,000 | 0 | 0 |